Doctors can report bad drug ads to the FDA
by John Gever
A new FDA program seeks to enlist healthcare professionals in flagging improper sales tactics for prescription drugs.
Although the agency calls the program “Bad Ad,” its interest goes beyond broadcast and print advertisements to include misleading in-person presentations.
Housed within the Division of Drug Marketing, Advertising, and Communication (DDMAC), the program is intended to increase the number of eyes and ears available to monitor pharmaceutical companies’ promotional activities — especially …
Doctors can report bad drug ads to the FDA


















